"This strategy means that SCVs can be considered as 'dormant forms' of infections which can rapidly regain their full virulence and cause a patient to relapse," concluded L?ffler. "This has important clinical implications as it means that targeting phenotype switching could prevent the bacteria from hiding, making the infection more vulnerable to host response and treatment."